There has been much discussion about protracted shortages of critical medicines in the Czech Republic over the last couple of months. Many national measures have been adopted. At the European Union level,the Voluntary Solidarity Mechanism for medicines has been put in place.

PRK Partners has advised Affimed on its successful divestment of AbCheck to Flagship Pioneering company Ampersand Biomedicines.

Dan Minoiu has become a new Deputy Managing Partner at Musat & Asociatii, while Ana Maria Abrudan, Mateea Codreanu, and Stefan Diaconescu have all been promoted to Partner positions.

Attorneys-at-Law Wojciech Kulczyk and Krzysztof Sikorski have been elevated to Partner positions with WKB Lawyers at the start of 2024.

Tuca Zbarcea & Asociatii has advised the Amethyst Radiotherapy Group on the sale and lease-back of three buildings to the BT Property Alternative Real Estate Investment Fund.

Schoenherr has advised Ceres Pharma on the acquisition of the Hungarian pharmaceutical companies VitaPlus and Innopharm, including their Innopharm Austrian subsidiary.